Smokers switching exclusively to glo significantly reduce exposure to certain toxicants

November 05, 2020

New research by BAT has found that smokers who switched completely from smoking cigarettes to using BAT's flagship tobacco heating product (THP), glo, substantially reduced their exposure to certain cigarette smoke toxicants over three months.

For many of the toxicants measured, the levels found in participants were similar to those in people that stopped using tobacco completely.

This supports BAT's ambition to build A Better Tomorrow by reducing the health impact of its business, given respected public health agencies say that to be considered a modified risk tobacco product, switching completely should have a similar outcome for the smoker to quitting.

Scientists at BAT are conducting the UK's first ever year-long controlled study to see what impact switching from cigarettes to glo will have on general health as well as smoke-toxicant exposure.

Today's results find that smokers who switch from cigarettes to glo exclusively significantly reduce the levels of harmful toxicants they are exposed to, potentially reducing their risk of developing smoking-related diseases. Further results from this study will provide more evidence to help understand the impact of switching to glo and will be announced once the study has been completed.

Dr James Murphy, Group Head of Potentially Reduced-Risk Product Science, commented: "These initial results regarding glo are extremely encouraging - glo provides smokers who wish to continue using tobacco and nicotine products with a potentially reduced risk alternative to cigarettes. The results are another positive step for BAT as we continue our journey to reduce the health impact of our business by offering consumers a range of enjoyable and potentially reduced-risk products."
-end-
Notes to editors:

About BAT

BAT is a leading, multi-category consumer goods business, established in 1902. Our purpose is to build A Better Tomorrow by reducing the health impact of our business through offering a greater choice of enjoyable and less risky products for our consumers. Our ambition is to increasingly transition our revenues from cigarettes to non-combustible products over time.

About glo

Our flagship THP - glo - comprises a battery-powered device that heats specially designed tobacco sticks to below 300 degrees Celsius. This process produces a nicotine-containing aerosol with a tobacco taste which the user inhales. glo was designed in the UK, but the design process involved more than 100 experts across five continents, including scientists, engineers, product designers, tobacco specialists and toxicologists. The glo device is one unit, with one button, making it simple and intuitive to use. As the tobacco sticks aren't burned, no ash is produced and there is less odour and less staining compared to conventional cigarette.

About the study

The data has been published in Nicotine and Tobacco Research.

The year-long study involves smokers aged 23 to 55 in good general health, and "never smokers" who serve as controls. The smoker volunteers who indicated that they did not intend to quit smoking have been randomised to either continue smoking cigarettes or switch to using only glo for a year, while smoker volunteers who indicated that they wanted to quit smoking receive nicotine replacement therapy. The smokers who want to quit also have access to a cessation counsellor. The "never smokers" act as controls.

During the year, participants visit one of the four UK clinics running the study, and every month biomarkers of exposure to selected cigarette smoke toxicants are measured in urine, along with exhaled carbon monoxide. Health indicators are measured at the same time.

The full study will determine whether reduced exposure is maintained over six months and a year, and whether it is associated with beneficial changes in health effect indicators. Six-month results are expected later this year.

Enquiries


British American Tobacco Press Office:
Lydia Meakin / Anna Vickerstaff

+44 (0) 20 7845 2888 (24 hours) | @BATPress

R&D at British American Tobacco

Related Tobacco Articles from Brightsurf:

UC studies tobacco use, cancer connection
Researchers at the University of Cincinnati have identified new clues into ways tobacco use impacts patients with kidney cancer.

'Best' hospitals should be required to deliver tobacco treatment
A UCLA-led report published today in the Journal of the American Medical Association Internal Medicine exposes what the authors call a weakness in the high-profile 'Best Hospitals Honor Roll' published annually by US News and World Report.

Small shops, heavy advertisers less likely to ID for tobacco
'Our findings suggest that certain types of stores -- tobacco shops, convenience stores and those with a lot of tobacco advertising -- are more likely to sell tobacco to a young person without checking his or her ID.'

Youth smoking and vaping: What does it mean for tobacco control
New research from PIRE/PRC features analysis of in-depth, qualitative interviews with young vapers in California between 15 and 25.

Truth telling about tobacco and nicotine
In 'Truth Telling about Tobacco and Nicotine,' PRC researchers explain that, although there is agreement among researchers about evidence that vaping can be less harmful than combustible cigarettes, the tobacco control community remains divided about how to communicate -- or even whether to communicate -- information about the relative risks of tobacco and nicotine products.

A 'joint' problem: Investigating marijuana and tobacco co-use
A survey of marijuana and tobacco co-users by Medical University of South Carolina investigators found that co-users with high degree of interrelatedness between their use of the two substances had greater tobacco dependence and smoked more cigarettes per day.

How genes affect tobacco and alcohol use
A new study gives insight into the complexity of genetic and environmental factors that compel some of us to drink and smoke more than others.

Tobacco use linked with higher use of opioids and sedatives
Tobacco is a known risk factor for the misuse of prescription opioids.

Changes in flavored tobacco product use among youth tobacco users
Self-reportedĀ use of flavored tobacco products by middle and high school students decreased from 2014 to 2016 but climbed back up in 2017 in an analysis of national survey data.

Heated tobacco product claims by tobacco industry scrutinized by UCSF researchers
Claims by the tobacco industry that heated tobacco products (HTPs) are safer than conventional cigarettes are not supported by the industry's own data and are likely to be misunderstood by consumers, according to research published in a special issue of Tobacco Control.

Read More: Tobacco News and Tobacco Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.